Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP | P19971 | 1/20 | 0.36 |
| ▸ | TK2 | O00142 | 9/20 | 0.33 |
| ▸ | TK1 | P04183 | 5/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL34460009 | 0.89 | TYMP (0.33) | TYMP | |
| SCHEMBL34460008 | 0.87 | TYMP (0.33) | TYMP | |
| SCHEMBL31570211 | 0.86 | TYMP (0.36) | TYMPTK2TK1 | |
| SCHEMBL31723473 | 0.84 | RNASE1 (0.40) | TK2TK1 | |
| SCHEMBL7261209 | 0.84 | TYMP (0.36) | TYMPTK2TK1 | |
| SCHEMBL29530844 | 0.83 | TYMP (0.35) | TYMPTK2TK1 | |
| SCHEMBL2113954 | 0.81 | TYMP (0.36) | TYMPTK2TK1 | |
| SCHEMBL327187 | 0.80 | TK2 (0.35) | TYMPTK2TK1 | |
| SCHEMBL313048 | 0.79 | TYMP (0.44) | TYMPTK2TK1 | |
| SCHEMBL30216573 | 0.79 | TYMP (0.47) | TYMPTK2TK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250346624-A1 | POLYNUCLEOTIDE AND PRODUCING METHOD THEREOF | EISAI R&D MAN CO LTD (JP) | 2025-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250346624-A1 | POLYNUCLEOTIDE AND PRODUCING METHOD THEREOF | POLRMT, POLN, POLM | TYMP 19/4885TK2 107/4885TK1 252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.